MHRA opens consultation for reclassification of drugs

07 Oct 2008

• By Becky Debens

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued public consultations for the reclassification of four pharmacy drugs: Freederm Gel (4% nicotinamide), Bazuka gel (salicylic acid 12% w/w and lactic acid 4.0% w/w), Hedrin lotion (dimeticone 4%) and Nicorette nasal spray (nicotine 10mg/ml).

The public consultations call for views on each product to change their status from Pharmacy (P) to General Sales List...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Leo Keeps On Profitable Path With Solid H1 Sales Growth

18 Aug 2025

• By Kevin Grogan

The Danish firm's atopic dermatitis drug Adbry is performing well despite strong competition from Sanofi/Regeneron’s Dupixent.

UCB Takes A Bow as Bimzelx HS Launch Achieves Lift-Off

01 Aug 2025

• By Manas Mishra

The Belgian company has raised its outlook for full-year sales following a strong launch for Bimzelx in hidradenitis suppurativa in the first half of 2025.